Related Experiment Video
Updated: Apr 21, 2026
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Myocardial Natriuretic Peptides and Oxygen Metabolism in Heart Failure
1Biodiversity Unit, University of Turku Turku, Finland.
Insights
Natriuretic peptides, crucial in heart failure (HF) management, may be regulated by hypoxia, not just myocardial stretch. Hypoxia-inducible factor directly stimulates natriuretic peptide expression in heart cells.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Natriuretic peptides (NPs) are standard biomarkers in heart failure (HF) management.
- Elevated NP levels in HF are traditionally attributed to myocardial stretch.
- Existing systematic reviews on NPs in HF have yielded inconclusive results.
Purpose of the Study:
- To investigate the role of myocardial oxygen metabolism in regulating natriuretic peptide levels in HF.
- To explore the hypoxia-inducible factor (HIF) pathway as a potential regulator of NP expression.
Main Methods:
- Review of existing literature on natriuretic peptides, heart failure, and hypoxia.
- Analysis of studies on myocardial stretch and oxygen consumption in HF.
- Examination of in vitro studies demonstrating hypoxia's effect on NP expression via HIF.
Main Results:
- Myocardial stretch, while influencing oxygen consumption, has not been definitively linked to NP levels in HF.
- Hypoxia-inducible factor acts as an oxygen sensor in myocardial cells.
- Hypoxia directly stimulates natriuretic peptide expression through the HIF pathway in myocardial cell cultures.
Conclusions:
- Myocardial oxygen metabolism, regulated by hypoxia via HIF, offers a novel perspective on elevated natriuretic peptide levels in HF.
- This pathway presents a new, objective target for future clinical research in heart failure.
Abstract:
Since the discovery of natriuretic peptides in the 1980s, initially as A-type natriuretic peptide, followed by B-type natriuretic peptide, their measurement has become standard in the management of heart failure (HF), as levels are markedly elevated in patients with HF. However, systematic reviews conducted in this area have yielded inconclusive results. Position and consensus papers on natriuretic peptides and HF have uniformly adopted the paradigm that myocardial stretch is the underlying mechanism explaining elevated circulating natriuretic peptide levels. Although mechanical stress is the primary factor determining myocardial oxygen consumption, this relationship has not been studied in HF. Biological evolution has developed a specific hypoxia-sensitive pathway in which a nuclear transcription factor, hypoxia-inducible factor, serves as the oxygen sensor, enabling myocardial cells to respond to reduced oxygen tension. In myocardial cell cultures, hypoxia was found to be a direct and sufficient stimulus for the expression of natriuretic peptides via the hypoxia-inducible factor pathway. Myocardial oxygen metabolism, which regulates plasma natriuretic peptide levels, presents a new objective for clinical research in HF.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Related Concept Videos
01:29Heart Failure II: Pathophysiology
01:30Heart Failure V: Medical Management
01:22Heart Failure VI: Adjunct Therapies
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:17Pathophysiology of Heart Failure
01:29Cardiomyopathy VI: Nursing Management